Ironwood Pharmaceuticals, Inc. (IRWD) vs Prime Medicine, Inc. (PRME)

A side-by-side comparison of Ironwood Pharmaceuticals, Inc. and Prime Medicine, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — IRWD vs PRME

growth of $100 · dividends reinvested · last 4y
IRWD -63.6% (-22.3%/yr)PRME -79.1% (-32.4%/yr)IRWD compounded faster over this window
050100150Start $1002023202420252026$36$21
IRWD PRME

IRWD vs PRME: by the numbers

  • •PRME is the larger company ($628M vs $600M market cap).
  • •IRWD is profitable (33.36% net margin) while PRME runs a net loss (-4613.11%).
  • •Both shrank revenue over the past five years; IRWD's decline was smaller (-1.18% vs -2.32% CAGR).

Metrics side by side

Valuation

MetricIRWDPRME
P/E ratio4.75N/A
Forward P/E2.98N/A
P/S ratio1.54154.30
P/B ratioN/A15.79
EV / EBITDA3.86N/A
FCF yield30.92%N/A

Profitability

MetricIRWDPRME
Gross margin99.76%-58.05%
Operating margin40.10%-4498.06%
Net margin33.36%-4613.11%
ROEN/A-471.98%
ROIC58.60%-90.42%

Growth (annualized)

MetricIRWDPRME
Revenue CAGR (5Y)-1.18%-2.32%
EPS CAGR (5Y)-25.87%N/A
FCF CAGR (5Y)-3.98%N/A
Total return CAGR (5Y)-22.82%N/A

Frequently asked

Which has grown faster, IRWD or PRME?
Neither grew: over the past five years both shrank revenue, with IRWD's decline the smaller — IRWD at a -1.18% CAGR versus PRME at -2.32%.
Is IRWD or PRME more profitable?
IRWD runs the higher net margin — IRWD at 33.36% versus PRME at -4613.11%.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.